Scenesse and MT 7117 are tied as an effective treatment for EPP. DISC is the clear front runner as the go to future treatment if approved.
When can we assume DISC will receive FDA approval?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$11.26 |
Change
0.460(4.26%) |
Mkt cap ! $566.3M | |||
| Open | High | Low | Value | Volume |
| $11.00 | $11.45 | $10.88 | $994.6K | 89.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 213 | $11.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.28 | 85 | 7 |
View Market Depth
| Last trade - 13.15pm 16/09/2025 (20 minute delay) ? |
| CUV (ASX) Chart |